Researchers grow immune cells with more targeted cancer-fighting abilities

Researchers at the University of California, Berkeley, have made a groundbreaking discovery that could revolutionize the way we treat diseases, particularly cancer, by enhancing the targeted abilities of immune cells. Their findings, published in the journal Advanced Materials, suggest that the stiffening of lymph nodes may play a crucial role in activating the immune system to combat serious infections or threats. This new understanding could lead to a revolutionary method for manufacturing immune cells, maximizing their cancer-fighting abilities while minimizing side effects.

Lymph nodes are often referred to as the command centers of the immune system, as they filter and respond to pathogens and foreign substances. When these nodes become swollen and stiff, it is typically a sign that the body is actively fighting an infection. The Berkeley team's research delved into how immune cells, specifically T cells or lymphocytes, respond to different mechanical environments. To mimic the surface of a natural lymph node, the researchers exposed T cells to hydrogels with varying levels of stiffness.

The study revealed that T cells activated on stiffer materials were more effective at killing target cancer cells. However, cells activated on softer materials demonstrated greater precision, targeting only the intended cells with fewer off-target effects. This dual capability highlights the importance of the mechanical environment in modulating immune cell behavior.

Derfogail Delcassian, assistant professor of bioengineering and the study's principal investigator, explained that the stiffening of lymph nodes serves as a mechanism to activate immune cells to respond aggressively to serious infections or threats. Delcassian also noted that a "soft activation" approach can help create T cells that are more precise in their targeting, reducing unwanted side effects.

Currently, T cell and CAR-T cell therapies are manufactured using a "stiff activation" approach. While this method can be highly effective in treating cancer, it can sometimes lead to excessive aggression, causing the immune cells to attack off-target cells. This can result in hyperinflammation and other adverse effects for patients. Conversely, in the case of autoimmune diseases, overly aggressive T cells can exacerbate the condition.

The Berkeley researchers' discovery offers a potential solution to this challenge. By understanding the role of mechanical stiffness in immune cell activation, they can now develop a more controlled method for manufacturing immune cells. This advancement has the potential to make T cell and CAR-T cell therapies more suitable for a wider range of diseases, thereby limiting off-target side effects and improving patient outcomes.

In conclusion, the groundbreaking research conducted by the UC Berkeley team has shed light on the intricate relationship between mechanical environments and immune cell function. By harnessing this knowledge, scientists can now develop more targeted and effective therapies for various diseases, including cancer, while minimizing the risk of harmful side effects. This innovative approach not only holds promise for improving current treatments but also paves the way for future advancements in immunotherapy and personalized medicine.